Rahul Gupta, Commissioner and State Health Officer for the West Virginia Bureau for Public Health
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial
I kept a running log of my symptomspain, swelling, and itchingquantifying the severity on a scale from 0 (asymptomatic) to 10 (severe)
[DOI] [PubMed] [Google Scholar] 97.Brusick D, Aardema MJ, Allaben WT, Kirkland DJ, Williams G, Llewellyn GC, et al
The FDA also may withdraw the initial and any potential subsequent exposure modification orders if the agency determines that, among other things, the orders are no longer expected to benefit the health of the population as a whole, for example as a result of an uptake in use of the products by youth or former smokers, or a decrease in the number of current smokers who completely switch to the products
